Supply chain threats and API exploits aren’t just pharma problems anymore. Here’s what CISOs, data vendors, and care platforms must act on now.

A recent article from Help Net Security lays out what CISOs in pharma are facing in 2025, and it’s not just a pharma problem.

The new threat landscape extends deep into healthcare’s shared data ecosystem, from API vulnerabilities to supply chain attacks. Health tech platforms, provider–payer networks, and data infrastructure vendors are all in the blast radius.

• Overexposed Supply Chains
  Pharma increasingly relies on third-party vendors for R&D and manufacturing,  and attackers know it.
• Unsecured APIs
  APIs connecting provider, payer, and research systems are entry points when authentication and encryption are weak.
• Endpoint Proliferation
  In decentralized trials, field tools, remote tablets, and mobile apps are rapidly expanding the attack surface.

At Madaket, our provider data infrastructure supports 85% of U.S. providers. That means we have a front-row seat to the rising stakes of cybersecurity. Here’s what we recommend for health tech platforms and data vendors:

• Harden all API gateways with full access monitoring and strong authentication protocols.
• Adopt Zero Trust across every provider, partner, and research data exchange.
• Build shared incident response protocols with pharma and ecosystem partners.

Our infrastructure is built with:

• Encrypted EDI data pipelines
• Role-based access and full audit logging
• Continuous security testing and third-party validation

As pharma and healthcare converge, security is no longer a siloed function; it’s a shared responsibility and a competitive differentiator.

Original article:

CISO Pharma Cybersecurity Risks — Help Net Security